Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Racism and heart disease. This study looks at heart failure patients and the impact of socioeconomic disparities associate with epigenetics. The study looks to overcome preconcieved ideas about race in cardiac studies by looking at underlaying causes for the disease. Image courtesy of the American Journal of Physiology

News | Heart Failure

Socioeconomic Disparities Associate With Epigenetics and Heart Failure Outcomes

April 26, 2021 – Cardiovascular diseases are the leading cause of death in the United States. Heart failure disproportio ...

April 26, 2021

News

North American COVID-19 STEMI Research Reveals High Mortality and Atypical Symptoms

April 20, 2021 – The Minneapolis Heart Institute Foundation (MHIF) announced the first publication of outcomes from the ...

April 20, 2021

The reSept ASD Occluder is the first structural heart occluder with a metal-free, bioresorbable frame. The novel implant is designed to overcome the limitations of current transcatheter occluders. It is hoped the design will reduce the risk of complications associated with the long-term presence of metal in the heart and to preserve future treatment options requiring transseptal intervention.

News | Structural Heart Occluders

Bioresorbable ASD Occluder Prepares to Enter U.S. Clinical Trial

April 20, 2021 — Start-up medical device company atHeart Medical announced it is initiating its U.S. investigational ...

April 20, 2021

The Elixer Dynamx Coronary Bioadaptor Stent technology uses a bioresorbable polymer that dissolves after three months and disconnected joints between numerous stent segments, allowing it to articulate and share to the vessel and movement.

News | Stents

First Patient Treated in Elixer Dynamx Coronary Bioadaptor Stent Technology

April, 14, 2021 – Elixir Medical recently announced the first patient was treated in the BIOADAPTOR randomized ...

April 14, 2021

COVID-19 disrupted all aspects of science and medicine and unmasked striking disparities and opportunities for transformation. Coronavirus impact this past year is expected to result in a massive rise in new cases of chronic health conditions, including cardiolvascular disease and heart failure.

News | Coronavirus (COVID-19)

Tsunami of Chronic Health Conditions Expected Due to COVID-19 Disruption of Healthcare

April 6, 2021 — A tsunami of chronic health conditions as a result of the COVID-19 (SARS-CoV-2) pandemic, especially car ...

April 07, 2021

The Acutus Medical AcQBlate Force sensing ablation catheter.

News

Acutus Medical Initiates First IDE Therapy Trial With AcQBlate Force Sensing Ablation System

April 5, 2021 — Acutus Medical today announced initial U.S. enrollments in the company’s AcQForce Flutter ...

April 05, 2021

Videos | Coronavirus (COVID-19)

VIDEO: Antithrombotic Prophylaxis in COVID-19 Patients

Behnood Bikdeli M.D., a cardiologist at the Brigham and Women’s Hospital, Harvard Medical School, Boston, offers an ...

April 01, 2021

Researchers found a relationship between stress-associated neurobiological activity on 18F-FDG PET-CT imaging and risk for subsequent Takotsubo syndrome impacting the heart.

News

PET-CT Shows Stressed Brain Linked to Broken Heart

March 31, 2021 — Heightened activity in the brain, caused by stressful events, is linked to the risk of developing a ...

March 31, 2021

Videos | Structural Heart

VIDEO: PFO Closure Shows Continued Stroke Prevention Benefit at 5 Years

Interview with Scott E. Kasner, M.D., who served as the principle investigator for the Gore Cardioform REDUCE trial, and ...

March 23, 2021

Top left, electromechanical wave imaging (EWI) isochrone renderings showing the activation points of the myocardium based on echocardiography axial strain measurements. Bottom right, EWI images overlaid on patient's CT scan of the heart.

News | EP Lab

New Ultrasound Technique Helps Pinpoint Source of Arrhythmias

March 23, 2021 — Researchers at Columbia University are using cardiac ultrasound to improve the critical need to ...

March 23, 2021

MRI scan of a damaged heart. Blue means reduced blood flow, orange is good blood flow. In this figure the inferior part of the heart shows dark blue, so the myocardial blood flow is very reduced. The angiogram shows the coronary artery which supplies the blood to this part of the heart is occluded. The three colored MRI images show different slices of the heart — the basal mid and apical slices. Image courtesy of European Heart Journal #COVID #COVID19

News | Coronavirus (COVID-19)

Heart Damage Found in More Than Half of COVID-19 Patients Discharged From Hospitals

March 17, 2021 — Around 50% of patients who have been hospitalized with severe COVID-19 (SARS-CoV-2) and have damage to ...

March 17, 2021

A study from Washington University School of Medicine in St. Louis provides evidence that the coronavirus can invade and replicate inside heart muscle cells, causing cell death and interfering with heart muscle contraction. The image of engineered heart tissue shows human heart muscle cells (red) infected with COVID-19 (SARS-CoV-2) (green). Image by Lina Greenberg.

Feature | Coronavirus (COVID-19)

COVID-19 Can Kill Heart Cells and Interfere With Contraction

March 12, 2021 — Since early in the pandemic, COVID-19 has been associated with heart problems, including reduced ...

March 12, 2021

The Philips Stellarex low-dose paclitaxel drug-coated balloon prior to insertion in the cath lab. Five-year ILLUMENATE EU RCT and Pivotal Data Confirm Safety of Philips Stellarex Low-dose Drug-coated Balloon

News | Drug-Eluting Balloons

Five-year ILLUMENATE EU RCT and Pivotal Data Confirm Safety of Philips Stellarex Low-dose Drug-coated Balloon

March 12, 2021 — Philips Healthcare announced the final, five-year results of two major randomized controlled trials ...

March 12, 2021

Interactions between capillary function, inflammation, hypoxia, and neurotransmission. The expression of ACE2 and other SARS‐CoV‐2 entry factors on parenchymal cells and observations of infected cells in biopsy material hold important clues to understand COVID‐19‐related organ damage. COVID-19 Blood Vessel Damage May Cause Brain Fog and Other Long-hauler Symptoms

News | Coronavirus (COVID-19)

COVID-19 Blood Vessel Damage May Cause Brain Fog and Other Long-hauler Symptoms

March 12, 2021 — A new review suggests that blood vessel damage and impaired oxygen delivery related to COVID-19 play a ...

March 12, 2021

AMERICAN COLLEGE OF CARDIOLOGY (ACC) Late-breaking clinical trial study presentations at ACC.21. @ACC21 @ACC2021

Feature | ACC | Dave Fornell, Editor

ACC 2021 Late Breaking Cardiology Study Results

The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced ...

May 18, 2021